Multiple Myeloma is an incurable but treatable cancer that can affect the bones, kidneys and blood counts. It is treated with chemotherapy and often a bone marrow transplant. Bone pain, repeated infections and high levels of calcium in the blood are just a few symptoms.
The Avera Research Institute and the Avera Cancer Institute is conducting a unique study for patients with Multiple Myeloma
"The goal is to get what is called complete remission where all the abnormal lab tests that made us diagnose this condition become normal again," said Dr.Vinod Parameswaran, the principle investigator for the study
The study will determine the effectiveness of the investigational medication when combined with medications currently used to treat patients with this type of cancer.
"The way the treatment is being approached is to try to find out if this drug can be used to treat myeloma successfully," he said.
Multiple myeloma is a cancer of the plasma cell that is an incurable but treatable disease. Dr. Parameswaran said he's excited about this new treatment option. The investigational medication is an antibody that targets proteins on myeloma cells. It's a different method of attacking the cancer cells than what is currently being used
"We have to find a safe dose in combination with standard treatment that can be given to these patients," he said.
The majority of people who develop Multiple Myeloma are older than fifty, with most diagnosed around seventy.